Compounding & Regulatory
Compounding & Regulatory
Regulatory frameworks, compliance considerations, and the shortage-driven news shaping compounding pharmacy today.
← Back to Library
Compounding & Regulatory
503A vs. 503B: What the Distinction Means for Dermatology Compounding
Two different regulatory frameworks, two different quality standards, and two very different answers to "can we compound this."
Jul 27, 2026 Compounding & RegulatoryThe Triamcinolone Shortage: A Case Study in Compounding's Regulatory Edge
Intralesional triamcinolone is a dermatology workhorse, and it's been on the FDA shortage list for years. What that's meant for how practices actually source it.
Jul 27, 2026 Compounding & RegulatoryCompounding Formulation Reference
Bases, common extemporaneous preparations, and the stability variables that determine whether a compound actually holds up.
Jul 25, 2026